These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 27054972)

  • 1. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
    Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
    J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
    Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
    Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
    J Mol Graph Model; 2017 Oct; 77():338. PubMed ID: 28957754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
    Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
    J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
    J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
    J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.
    Nasir A; Samad A; Ajmal A; Li P; Islam M; Ullah S; Shah M; Bai Q
    Int J Biol Macromol; 2024 Jun; 272(Pt 1):132855. PubMed ID: 38834129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D; Mythily U; Rao K
    Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
    Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
    J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition.
    Mukhametov A; Newhouse EI; Aziz NA; Saito JA; Alam M
    J Mol Graph Model; 2014 Jul; 52():103-13. PubMed ID: 25023665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
    Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
    Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
    Purohit P; Barik D; Agasti S; Panda M; Meher BR
    J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of Carica papaya bioactive compounds as potential inhibitors of dengue NS2B, NS3 and NS5 protease.
    Farooq MU; Munir B; Naeem S; Yameen M; Iqbal SZ; Ahmad A; Mustaan MA; Noor MW; Nadeem MA; Ghaffar A
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):355-360. PubMed ID: 32122868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study.
    Shimu MSS; Mahmud S; Tallei TE; Sami SA; Adam AA; Acharjee UK; Paul GK; Emran TB; Zaman S; Uddin MS; Saleh MA; Alshehri S; Ghoneim MM; Alruwali M; Obaidullah AJ; Jui NR; Kim J; Kim B
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational discovery of dengue type 2 non-competitive inhibitors.
    Heh CH; Othman R; Buckle MJ; Sharifuddin Y; Yusof R; Rahman NA
    Chem Biol Drug Des; 2013 Jul; 82(1):1-11. PubMed ID: 23421589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
    Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
    Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
    Gurusamy M; Abdul JF
    Curr Drug Discov Technol; 2019; 16(3):307-314. PubMed ID: 29984660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.
    Hariono M; Choi SB; Roslim RF; Nawi MS; Tan ML; Kamarulzaman EE; Mohamed N; Yusof R; Othman S; Abd Rahman N; Othman R; Wahab HA
    PLoS One; 2019; 14(1):e0210869. PubMed ID: 30677071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach.
    Galiano V; Garcia-Valtanen P; Micol V; Encinar JA
    Drug Des Devel Ther; 2016; 10():3163-3181. PubMed ID: 27784988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.